PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-4.44%
Both yoy net incomes decline, with 1097.HK at -32.07%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-2.25%
Both reduce yoy D&A, with 1097.HK at -3.52%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.07%
Less working capital growth vs. 1097.HK's 311.22%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
No Data
No Data available this quarter, please select a different quarter.
-300.00%
Both reduce yoy inventory, with 1097.HK at -100.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
-97.77%
Negative yoy usage while 1097.HK is 280.31%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-405.88%
Negative yoy while 1097.HK is 50.75%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-23.07%
Negative yoy CFO while 1097.HK is 680.17%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-83.59%
Both yoy lines negative, with 1097.HK at -19.70%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-31.39%
Negative yoy acquisition while 1097.HK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-156.93%
Negative yoy purchasing while 1097.HK stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
56.48%
Liquidation growth of 56.48% while 1097.HK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
2.17%
We have some outflow growth while 1097.HK is negative at -71.19%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-294.08%
Both yoy lines negative, with 1097.HK at -36.28%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.